133 related articles for article (PubMed ID: 35690510)
1. Two-Staged Sacral Neuromodulation for the Treatment of Nonobstructive Urinary Retention: A Multicenter Study Assessing Predictors of Success.
Coolen RL; Groen J; Stillebroer AB; Scheepe JR; Witte LPW; Blok BFM
Neuromodulation; 2023 Dec; 26(8):1823-1830. PubMed ID: 35690510
[TBL] [Abstract][Full Text] [Related]
2. Sacral neuromodulation in patients with detrusor underactivity: Is biological sex an indicator?
Onur R; Tayebi S; Salehi-Pourmehr H; Jahantabi E; Perrouin-Verbe MA; Naseri C; Hajebrahimi S; Hashim H
Neurourol Urodyn; 2022 Mar; 41(3):847-859. PubMed ID: 35181913
[TBL] [Abstract][Full Text] [Related]
3. Sensing in Sacral Neuromodulation: A Feasibility Study in Subjects With Urinary Incontinence and Retention.
Goudelocke C; Jungbauer Nikolas LM; Bittner KC; Offutt SJ; Miller AE; Slopsema JP
Neuromodulation; 2024 Feb; 27(2):392-398. PubMed ID: 37589643
[TBL] [Abstract][Full Text] [Related]
4. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
Girtner F; Burger M; Mayr R
Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
[TBL] [Abstract][Full Text] [Related]
5. Does sacral neuromodulation lead to relevant reduction in the need for intermittent catheterization? A single-center experience on patients with chronic urinary retention.
Denzinger S; Nowrotek A; Weingart P; Burger M; Wieland WF; Rößler W; Otto W
Neuromodulation; 2012; 15(6):586-91; discussion 591. PubMed ID: 22672285
[TBL] [Abstract][Full Text] [Related]
6. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.
Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE
Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317
[TBL] [Abstract][Full Text] [Related]
7. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.
Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG
J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028
[TBL] [Abstract][Full Text] [Related]
8. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation?
Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P
J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416
[TBL] [Abstract][Full Text] [Related]
9. Predictive Factors in Sacral Neuromodulation: A Systematic Review.
Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; Vrijens D; van Kerrebroeck P
Urol Int; 2022; 106(4):323-343. PubMed ID: 34058731
[TBL] [Abstract][Full Text] [Related]
10. Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome?
Jairam R; Marcelissen T; van Koeveringe G; van Kerrebroeck P
Neuromodulation; 2017 Dec; 20(8):830-835. PubMed ID: 28877395
[TBL] [Abstract][Full Text] [Related]
11. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
Hoda MR; Fornara P
Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique.
Adelstein SA; Lee W; Gioia K; Moskowitz D; Stamnes K; Lucioni A; Kobashi KC; Lee UJ
Neurourol Urodyn; 2019 Aug; 38(6):1595-1601. PubMed ID: 31044466
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of sacral neuromodulation and percutaneous tibial nerve stimulation in the treatment of chronic nonobstructive urinary retention: A systematic review.
Ho FCS; He C; Yao HH; O'Connell HE; Gani J
Neurourol Urodyn; 2021 Jun; 40(5):1078-1088. PubMed ID: 33973670
[TBL] [Abstract][Full Text] [Related]
14. Preliminary analysis of stimulation parameters for sacral neuromodulation in different indications: a multicenter retrospective cohort study from China.
Meng L; Yan Z; Wang X; Zhang Y; Zhu Z; Zhu W; Ling Q; Sun X; Gu Y; Lv J; Li Y
Int J Surg; 2024 Jun; 110(6):3536-3542. PubMed ID: 38445489
[TBL] [Abstract][Full Text] [Related]
15. Sacral Neuromodulation: Determining Predictors of Success.
Morgan TN; Pace N; Mohapatra A; Ren D; Kunkel G; Tennyson L; Shepherd JP; Chermansky CJ
Urology; 2021 Jul; 153():124-128. PubMed ID: 32619594
[TBL] [Abstract][Full Text] [Related]
16. The value of urodynamic tools to guide patient selection in sacral neuromodulation.
Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P
World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936
[TBL] [Abstract][Full Text] [Related]
17. Improving clinical outcomes for women with overactive bladder or urinary retention symptoms: a comparison of motor response voltages (1-9 V) during Stage 1 sacral neuromodulation.
Marinkovic SP; Ford JC
BJU Int; 2018 Sep; 122(3):472-479. PubMed ID: 29637712
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pre-operative bladder contractility as a predictor of improved response rate to a staged trial of sacral neuromodulation in patients with detrusor underactivity.
Chan G; Qu LG; Gani J
World J Urol; 2021 Jun; 39(6):2113-2119. PubMed ID: 32725304
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Duration of Complaints on Successful Outcome of Sacral Neuromodulation.
Jairam R; Drossaerts J; van Koeveringe G; van Kerrebroeck P
Urol Int; 2017; 99(1):51-55. PubMed ID: 28478446
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of sacral neuromodulation with the tined lead procedure.
Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG
J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
